These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Parkinson's disease: distribution of Lewy bodies and monoamine neuron system. Ohama E; Ikuta F Acta Neuropathol; 1976 Apr; 34(4):311-9. PubMed ID: 179263 [TBL] [Abstract][Full Text] [Related]
7. Involvement of non-opioid peptides in the pathogenesis of neurological and psychiatric disorders: evidence from CSF and post-mortem studies. Nemeroff CB; Bissette G Prog Clin Biol Res; 1985; 192():333-41. PubMed ID: 2934745 [TBL] [Abstract][Full Text] [Related]
8. Cerebral metabolic relationships for selected brain regions in Alzheimer's, Huntington's, and Parkinson's diseases. Metter EJ; Riege WH; Kameyama M; Kuhl DE; Phelps ME J Cereb Blood Flow Metab; 1984 Dec; 4(4):500-6. PubMed ID: 6238975 [TBL] [Abstract][Full Text] [Related]
9. Amine accumulation: a possible precursor of Lewy body formation in Parkinson's disease. Sandyk R; Willis GL Int J Neurosci; 1992 Sep; 66(1-2):61-74. PubMed ID: 1304571 [TBL] [Abstract][Full Text] [Related]
11. Does impairment of energy metabolism result in excitotoxic neuronal death in neurodegenerative illnesses? Beal MF Ann Neurol; 1992 Feb; 31(2):119-30. PubMed ID: 1349466 [TBL] [Abstract][Full Text] [Related]
12. Loss of striatal histamine H2 receptors in Huntington's chorea but not in Parkinson's disease: comparison with animal models. Martínez-Mir MI; Pollard H; Moreau J; Traiffort E; Ruat M; Schwartz JC; Palacios JM Synapse; 1993 Nov; 15(3):209-20. PubMed ID: 7904088 [TBL] [Abstract][Full Text] [Related]
13. Oxidative stress and neurotoxicity. Sayre LM; Perry G; Smith MA Chem Res Toxicol; 2008 Jan; 21(1):172-88. PubMed ID: 18052107 [TBL] [Abstract][Full Text] [Related]
14. Presence of tau pathology within foetal neural allografts in patients with Huntington's and Parkinson's disease. Cisbani G; Maxan A; Kordower JH; Planel E; Freeman TB; Cicchetti F Brain; 2017 Nov; 140(11):2982-2992. PubMed ID: 29069396 [TBL] [Abstract][Full Text] [Related]
15. Immunocytochemical studies on the basal ganglia and substantia nigra in Parkinson's disease and Huntington's chorea. Waters CM; Peck R; Rossor M; Reynolds GP; Hunt SP Neuroscience; 1988 May; 25(2):419-38. PubMed ID: 2456487 [TBL] [Abstract][Full Text] [Related]
16. The Role of Reactive Oxygen Species in the Pathogenesis of Alzheimer's Disease, Parkinson's Disease, and Huntington's Disease: A Mini Review. Manoharan S; Guillemin GJ; Abiramasundari RS; Essa MM; Akbar M; Akbar MD Oxid Med Cell Longev; 2016; 2016():8590578. PubMed ID: 28116038 [TBL] [Abstract][Full Text] [Related]
17. Beta-adrenergic receptor subtypes in the basal ganglia of patients with Huntington's chorea and Parkinson's disease. Waeber C; Rigo M; Chinaglia G; Probst A; Palacios JM Synapse; 1991 Aug; 8(4):270-80. PubMed ID: 1656540 [TBL] [Abstract][Full Text] [Related]
19. Alterations in angiotensin AT1 and AT2 receptor subtype levels in brain regions from patients with neurodegenerative disorders. Ge J; Barnes NM Eur J Pharmacol; 1996 Feb; 297(3):299-306. PubMed ID: 8666063 [TBL] [Abstract][Full Text] [Related]